(Q46456132)

English

Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome

scientific article published in May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

Alzheimer's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Prasher VP

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

Fung N

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

Adams C

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

language of work or name

0 references

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

International Journal of Geriatric Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

20

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

496-497

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

Cholinergic therapy for Down's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1306

7 January 2021

based on heuristic

inferred from DOI database lookup

Down syndrome and Alzheimer disease: response to donepezil

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1306

7 January 2021

based on heuristic

inferred from DOI database lookup

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study.

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1306

7 January 2021

based on heuristic

inferred from DOI database lookup

Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population

1 reference

https://api.crossref.org/works/10.1002%2FGPS.1306

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/GPS.1306

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/15852458

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46456132&oldid=2112475685"